Follow
Keshab Rijal
Keshab Rijal
Wayne State University and NIH
Verified email at mail.nih.gov
Title
Cited by
Cited by
Year
Transcription termination by the eukaryotic RNA polymerase III
AG Arimbasseri, K Rijal, RJ Maraia
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1829 (3-4 …, 2013
1572013
Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation
AG Arimbasseri, K Rijal, RJ Maraia
Transcription 5 (1), e27369, 2014
1052014
Uremic solute-aryl hydrocarbon receptor-tissue factor axis associates with thrombosis after vascular injury in humans
VB Kolachalama, M Shashar, F Alousi, S Shivanna, K Rijal, ...
Journal of the American Society of Nephrology 29 (3), 1063-1072, 2018
1032018
Evolving specificity of tRNA 3-methyl-cytidine-32 (m3C32) modification: a subset of tRNAsSer requires N6-isopentenylation of A37
AG Arimbasseri, J Iben, FY Wei, K Rijal, K Tomizawa, M Hafner, ...
Rna 22 (9), 1400-1410, 2016
862016
Targeting STUB1–tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk
M Shashar, ME Belghasem, S Matsuura, J Walker, S Richards, F Alousi, ...
Science translational medicine 9 (417), eaam8475, 2017
512017
A new role for cisplatin: probing ribosomal RNA structure
K Rijal, CS Chow
Chemical communications, 2008
472008
RNA polymerase III mutants in TFIIFα-like C37 that cause terminator readthrough with no decrease in transcription output
K Rijal, RJ Maraia
Nucleic acids research 41 (1), 139-155, 2013
432013
Amino acid-linked platinum (II) analogues have altered specificity for RNA compared to cisplatin
K Rijal, X Bao, CS Chow
Chemical Communications 50 (30), 3918-3920, 2014
382014
Lack of tRNA-i6A modification causes mitochondrial-like metabolic deficiency in S. pombe by limiting activity of cytosolic tRNATyr, not mito-tRNA
TN Lamichhane, AG Arimbasseri, K Rijal, JR Iben, FY Wei, K Tomizawa, ...
Rna 22 (4), 583-596, 2016
372016
Point mutations in the Rpb9-homologous domain of Rpc11 that impair transcription termination by RNA polymerase III
JR Iben, JK Mazeika, S Hasson, K Rijal, AG Arimbasseri, AN Russo, ...
Nucleic acids research 39 (14), 6100-6113, 2011
372011
A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum
A Zhang, K Rijal, SK Ng, K Ravid, V Chitalia
Journal of biological methods 4 (3), 2017
222017
A methods review on use of nonsense suppression to study 3′ end formation and other aspects of tRNA biogenesis
K Rijal, RJ Maraia, AG Arimbasseri
Gene 556 (1), 35-50, 2015
192015
Active Center Control of Termination by RNA Polymerase III and tRNA Gene Transcription Levels In Vivo
K Rijal, RJ Maraia
PLoS genetics 12 (8), e1006253, 2016
182016
A transcriptional specialist resolved
RJ Maraia, K Rijal
Nature 528 (7581), 204-205, 2015
152015
Exploring potential drug target sites in the ribosome using cisplatin and its analogues
K Rijal
Wayne State University, 2011
32011
Amino acid-linked platinum (II) analogues have altered RNA adduct profiles compared to cisplatin
CS Chow, X Bao, C He, B Kimutai, K Rijal, MT Rodgers
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY 22, S170-S170, 2017
2017
Synthesis, characterization, and RNA reactivity of cisplatin analogs
X Bao, K Rijal, J Jiang, MT Rodgers, CS Chow
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014
2014
The ribosome: versatile drug target site
K Rijal
SONSIK JOURNAL 3, 15-22, 2011
2011
Cloning, expression and comparison of cytochromes p450 from Streptomyces hygroscopicus NRRL3602 with its homologues
K Rijal, HC Lee, JK Sohng
J. Biomolecule Reconstruction 1, 9-24, 2004
2004
The system can't perform the operation now. Try again later.
Articles 1–19